MYB and diffuse astrocytoma: As mentioned previously, there is a trend toward collectively managing AG and diffuse astrocytoma, MYB- or MYBL1-alterations within the same spectrum, under the broader classification of MYB- or MYBL1-altered pLGGs [20].